MOVE insider transaction filings
Corvex, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-08. Screen MOVE transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | Demsey Seth — Co-Chief Executive Officer, Director | Conversion (C): 5,484,388 @ $0 · Conversion (C): 31,270 @ $0 · Conversion (C): 5,484.39 (derivative) @ $0 · Conversion (C): 31.27 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Crystal John Adler III — Co-Chief Executive Officer, Director | Conversion (C): 3,345,523 @ $0 · Conversion (C): 708,154 @ $0 · Conversion (C): 3,345.52 (derivative) @ $0 · Conversion (C): 708.15 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | FAIRBAIRN EMILY — Director | Conversion (C): 1,205,282 @ $0 · Conversion (C): 1,205.28 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Moreland Christopher — CFO | Grant/award (A): 523,211 @ $0 | EDGAR |
| 2026-07-02 | 4 | Cullinan Brian — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-07-02 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 135,800 @ $0 · Disposition to issuer (D): 858.54 (derivative) @ $0 · Grant/award (A): 858.54 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Fleury Patrick — Director | Grant/award (A): 100,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | DONOFRIO NICHOLAS M — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-06-30 | 4 | Cullinan Brian — Director | Option exercise (M): 48,209 @ $0.92 · Option exercise (M): 48,209 (derivative) @ $0 | EDGAR |
| 2026-06-26 | 4 | Caballero Ruben — Director | Option exercise (M): 29,197 @ $0.92 · Option exercise (M): 29,197 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Demsey Seth — Director | Conversion (C): 24,532 @ $0 · Conversion (C): 139 @ $0 · Conversion (C): 24.53 (derivative) @ $0 · Conversion (C): 0.14 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Crystal John Adler III — Chief Executive Officer | Conversion (C): 14,965 @ $0 · Conversion (C): 3,167 @ $0 · Conversion (C): 14.97 (derivative) @ $0 · Conversion (C): 3.17 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | FAIRBAIRN EMILY — Director | Conversion (C): 9,231 @ $0 · Conversion (C): 9.23 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | Cogan Jeremy — CFO | Grant/award (A): 37,000 @ $0 | EDGAR |
| 2026-03-19 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 200,000 (derivative) @ $0 · Grant/award (A): 9.23 (derivative) @ $0 · Grant/award (A): 2,063.82 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | Wirk Shaheen — Director | Option exercise (M): 10,000 @ $1.25 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-03-17 | 4 | FAIRBAIRN EMILY — Director | Option exercise (M): 55,250 @ $1.25 · Option exercise (M): 55,250 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Mastrototaro John — Chief Executive Officer, Director | Option exercise (M): 72,834 @ $1.25 · Sale (S): 4,512 @ $19.12 · Sale (S): 5,444 @ $20.18 · Sale (S): 14,960 @ $20.75 · Sale (S): 5,746 @ $21.78 · Sale (S): 2,407 @ $23.37 · +1 more | EDGAR |
| 2026-01-28 | 4 | Cogan Jeremy — CFO | Option exercise (M): 64,834 @ $1.25 · Sale (S): 3,288 @ $19.11 · Sale (S): 4,622 @ $20.07 · Sale (S): 13,179 @ $20.63 · Sale (S): 5,548 @ $21.76 · Sale (S): 2,099 @ $23.37 · +1 more | EDGAR |
| 2026-01-22 | 4 | Leabman Michael Aaron — Chief Technology Officer, Director | Grant/award (A): 11,174 @ $0 | EDGAR |
| 2026-01-14 | 4 | Leabman Michael Aaron — Chief Technology Officer, Director | Sale (S): 3,377 @ $7.01 · Sale (S): 2,076 @ $6.94 · Sale (S): 6,845 @ $6.66 | EDGAR |
| 2026-01-13 | 4 | Mastrototaro John — Chief Executive Officer, Director | Grant/award (A): 11,919 @ $0 | EDGAR |
| 2026-01-12 | 4 | Cullinan Brian — Director | Grant/award (A): 4,768 @ $0 · Grant/award (A): 2,980 @ $0 | EDGAR |
| 2026-01-12 | 4 | Caballero Ruben — Director | Grant/award (A): 2,980 @ $0 · Grant/award (A): 2,980 @ $0 | EDGAR |
| 2026-01-12 | 4 | Wirk Shaheen — Director | Grant/award (A): 2,980 @ $0 · Grant/award (A): 2,980 @ $0 | EDGAR |
| 2026-01-12 | 4 | Cogan Jeremy — CFO | Option exercise (M): 20,000 @ $1.25 · Sale (S): 1,879 @ $8.35 · Sale (S): 3,859 @ $8.03 · Sale (S): 4,359 @ $7.57 · Grant/award (A): 9,299 @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 4,470 @ $0 · Grant/award (A): 5,959 @ $0 | EDGAR |
| 2026-01-12 | 4 | Leabman Michael Aaron — Chief Technology Officer, Director | Option exercise (M): 42,250 @ $1.25 · Sale (S): 3,293 @ $7.34 · Sale (S): 3,593 @ $7.26 · Sale (S): 783 @ $7.27 · Option exercise (M): 42,250 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Mastrototaro John — Chief Executive Officer, Director | Option exercise (M): 5,000 @ $1.25 · Sale (S): 2,514 @ $8.21 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Caballero Ruben — Director | Disposition to issuer (D): 8,295 @ $0 · Grant/award (A): 21,500 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Wirk Shaheen — Director | Disposition to issuer (D): 6,841 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Mastrototaro John — Chief Executive Officer, Director | Disposition to issuer (D): 39,226 @ $0 · Grant/award (A): 77,834 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Cogan Jeremy — CFO | Disposition to issuer (D): 31,871 @ $0 · Grant/award (A): 84,834 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Cullinan Brian — Director | Disposition to issuer (D): 13,271 @ $0 · Grant/award (A): 35,500 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | FAIRBAIRN EMILY — Director | Disposition to issuer (D): 12,442 @ $0 · Grant/award (A): 55,250 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Leabman Michael Aaron — Chief Technology Officer, Director | Disposition to issuer (D): 21,260 @ $0 · Grant/award (A): 42,250 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 31,028 @ $0 | EDGAR |
| 2025-10-07 | 4 | Wirk Shaheen — Director | Grant/award (A): 20,685 @ $0 | EDGAR |
| 2025-10-07 | 4 | Cullinan Brian — Director | Grant/award (A): 33,096 @ $0 | EDGAR |
| 2025-10-07 | 4 | Caballero Ruben — Director | Grant/award (A): 20,685 @ $0 | EDGAR |
| 2025-10-07 | 4 | Mastrototaro John — Chief Executive Officer, Director | Grant/award (A): 165,484 @ $0 | EDGAR |
| 2025-10-07 | 4 | Cogan Jeremy — CFO | Grant/award (A): 134,456 @ $0 | EDGAR |
| 2025-07-03 | 4 | Wirk Shaheen — Director | Grant/award (A): 18,657 @ $0 | EDGAR |
| 2025-07-03 | 4 | Caballero Ruben — Director | Grant/award (A): 18,657 @ $0 | EDGAR |
| 2025-07-03 | 4 | Cullinan Brian — Director | Grant/award (A): 29,851 @ $0 | EDGAR |
| 2025-07-03 | 4 | Mastrototaro John — Chief Executive Officer, Director | Grant/award (A): 149,257 @ $0 | EDGAR |
| 2025-07-03 | 4 | Cogan Jeremy — CFO | Grant/award (A): 121,272 @ $0 | EDGAR |
| 2025-07-03 | 4 | FAIRBAIRN EMILY — Director | Grant/award (A): 27,985 @ $0 | EDGAR |
| 2025-07-03 | 4 | Leabman Michael Aaron — Chief Technology Officer, Director | Grant/award (A): 139,925 @ $0 | EDGAR |
| 2025-05-13 | 4 | Mastrototaro John — Chief Executive Officer, Director | Grant/award (A): 77,521 @ $0 | EDGAR |
Recent 8-K events — Corvex, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-03-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MOVE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →